Christina Chu, MD
Gynecologic Oncology · Camden, NJNPI 1063444180
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $1,775 of the $1,890 with a category attached, or 93.9%. GSK accounts for 95.8% of it on its own, with 3 other manufacturers making up the rest.
Across 7 payments — averaging $270.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$2K
- Clovis Oncology, Inc.$39
- Merck$26
- CSL Behring$14
Across 327 payments — averaging $3071.95 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GSK$481K
- Deciphera Pharmaceuticals Inc.$293K
- Tesaro, Inc.$180K
- Seagen Inc.$32K
- Genmab U.S., Inc.$16K
- Merck$2K
What the payments were for
- Consulting fees$1,77594%
- Food & beverage$905%
- Education$261%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 4 | $1,811 |
| Clovis Oncology, Inc. | 1 | $39 |
| Merck | 1 | $26 |
| CSL Behring | 1 | $14 |
How this compares
$1,890 in reported general payments places this provider in the 65th percentile of 45 gynecologic oncology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dexamethasone | 22 | $695 |
| Prochlorperazine Maleate | 11 | $81 |
| Ibuprofen | 27 | $78 |
| Ondansetron Hcl | 14 | $64 |
| Oxycodone Hcl | 13 | $41 |
Paid to pharmacies, not to this prescriber.
Other gynecologic oncology in Camden
- David WarshalCamden$2K
- Marcia HernandezCamden$2K
- Meredith DuffyCamden$528
- Nida HasanCamden$81
- Sharyn LewinTeaneck$968K
- Scott RichardFlorham Park$84K
- Joyce VarughesePennington$16K
- James BosscherNeptune$13K
- Daniel TobiasMorristown$11K
- Karim ElsahwiNeptune$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.